Our data demonstrate the significance of the tumor-intrinsic STING-IFN-I signaling axis in the hDT806-induced tumor growth inhibition, and provide valuable insights into the development of novel immunotherapeutic approaches for treating HNSCC. This evidence concerns the gene STING1 and head and neck squamous cell carcinoma.